PATENT CLAIM ANALYSIS

Application Number: 16028704
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "007230"]

Abstract:
The invention generally relates to diagnostic, prognostic, and monitoring methods and assays for breast cancer and kits that may be used in such methods. More particularly, the invention relates to a method of prognosis of a patient afflicted with breast cancer, including determining the level of HER2/CB 2  heteromer expression in a biological sample obtained from the patient.

Claim (Index 14):
The method of  claim 1 , wherein HER2/CB 2  heteromers are bound to a fluorescent label and observed using a microscope.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 95.0
- Lexical Diversity: 1.45455
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13705048', '12821664', '12854144', '13829234', '12074229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6184537210770458
- 35 USC 102 Novelty (BERT): 0.4998524397255285
- Combined Prediction Score: 0.6065935929418941
- Mean Citation Score: 211.91263
- Max Citation Score: 232.68901
- Similarity Product: 152.2520331950742

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test